Cite
HARVARD Citation
Zhang, P. et al. (2023). Denosumab treatment for refractory hypercalcemia in a hemodialysis patient with tertiary hyperparathyroidism. Hemodialysis international. 27 (2), pp. E23-E28. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, P. et al. (2023). Denosumab treatment for refractory hypercalcemia in a hemodialysis patient with tertiary hyperparathyroidism. Hemodialysis international. 27 (2), pp. E23-E28. [Online].